E. Priestley

发表

Selection of a Thiazole Urea-Resistant Variant of Bovine Viral Diarrhoea Virus That Maps to the RNA-Dependent RNA Polymerase

J. Williams, H. Scarnati, R. King, 2002, Antiviral chemistry & chemotherapy.

Discovery of novel P1 groups for coagulation factor VIIa inhibition using fragment-based screening.

L. Mueller, D. Cheney, W. Metzler, 2015, Journal of medicinal chemistry.

Microscale purification in support of high-throughput medicinal chemistry.

C. Cavallaro, E. Priestley, Andrew F Donnell, 2021, Chemical communications.

Atropisomer Control in Macrocyclic Factor VIIa Inhibitors.

L. Mueller, D. Cheney, Yan Zou, 2016, Journal of medicinal chemistry.

Design and synthesis of potent, selective phenylimidazole-based FVIIa inhibitors.

D. Cheney, C. Weigelt, R. Wexler, 2015, Bioorganic & medicinal chemistry letters.

Nonbenzamidine acylsulfonamide tissue factor-factor VIIa inhibitors.

D. Cheney, C. Weigelt, Yan Zou, 2013, Bioorganic & medicinal chemistry letters.

Blockade of protease-activated receptor-4 (PAR4) provides robust antithrombotic activity with low bleeding

J. Guay, D. Seiffert, M. Bouvier, 2017, Science Translational Medicine.

Tissue factor-fVIIa inhibition: update on an unfinished quest for a novel oral antithrombotic.

E. Priestley, 2014, Drug discovery today.

Design of an N7-Glycosylated Purine Nucleoside for Recognition of GC Base Pairs by Triple Helix Formation

P. Dervan, J. Hunziker, E. Priestley, 1995 .

Neutral macrocyclic factor VIIa inhibitors.

Brandon L. Parkhurst, Wen Jiang, D. Cheney, 2017, Bioorganic & medicinal chemistry letters.

Discovery of Phenylglycine Lactams as Potent Neutral Factor VIIa Inhibitors.

Brandon L. Parkhurst, Wen Jiang, D. Cheney, 2016, ACS medicinal chemistry letters.

Synthesis and P1' SAR exploration of potent macrocyclic tissue factor-factor VIIa inhibitors.

Wen Jiang, D. Cheney, Yan Zou, 2016, Bioorganic & medicinal chemistry letters.

Discovery and gram-scale synthesis of BMS-593214, a potent, selective FVIIa inhibitor.

Jinglan Zhou, R. Knabb, R. Stanton, 2013, Bioorganic & medicinal chemistry letters.

Discovery of a Highly Potent, Selective, and Orally Bioavailable Macrocyclic Inhibitor of Blood Coagulation Factor VIIa-Tissue Factor Complex.

Brandon L. Parkhurst, Wen Jiang, D. Cheney, 2016, Journal of medicinal chemistry.

Design and Synthesis of Phenylpyrrolidine Phenylglycinamides As Highly Potent and Selective TF-FVIIa Inhibitors.

Wen Jiang, D. Cheney, Yan Zou, 2014, ACS medicinal chemistry letters.

BMS-593214, an active site-directed factor VIIa inhibitor: Enzyme kinetics, antithrombotic and antihaemostatic studies

R. Knabb, A. Rendina, B. Xin, 2010, Thrombosis and Haemostasis.

Structure-Based Design of Macrocyclic Coagulation Factor VIIa Inhibitors.

D. Cheney, A. Rendina, R. Wexler, 2015, Journal of medicinal chemistry.

Design and Synthesis of Novel Meta-Linked Phenylglycine Macrocyclic FVIIa Inhibitors.

D. Cheney, D. Seiffert, A. Rendina, 2017, ACS medicinal chemistry letters.

Discovery of Two Novel Antiplatelet Clinical Candidates (BMS-986120 and BMS-986141) That Antagonize Protease-Activated Receptor 4.

Shana L. Posy, A. Mathur, J. Guay, 2022, Journal of medicinal chemistry.

Discovery of Potent Protease-Activated Receptor 4 Antagonists with in vivo Antithrombotic Efficacy.

Shana L. Posy, D. Seiffert, Yanou Yang, 2019, Journal of medicinal chemistry.

Methylenecyclopropanecarboxylates and -dicarboxylates, efficient reagents for the [3 + 2] methylenecyclopentane annulation of unactivated and electron-rich alkenes

E. Priestley, K. Church, D. A. Singleton, 1991 .

P1 Phenethyl peptide boronic acid inhibitors of HCV NS3 protease.

C. Decicco, E. Priestley, I. De Lucca, 2002, Bioorganic & medicinal chemistry letters.

Design and Synthesis of New Aminoglycoside Antibiotics Containing Neamine as an Optimal Core Structure: Correlation of Antibiotic Activity with in Vitro Inhibition of Translation

Chi‐Huey Wong, S. Hung, E. Priestley, 1999 .

Sequence Composition Effects on the Energetics of Triple Helix Formation by Oligonucleotides Containing a Designed Mimic of Protonated Cytosine

P. Dervan, E. Priestley, 1995 .

Specificity of aminoglycoside antibiotics for the A-site of the decoding region of ribosomal RNA.

C. Wong, E. Priestley, M. Hendrix, 1998, Chemistry & biology.

Direct observation of aminoglycoside-RNA interactions by surface plasmon resonance.

G. F. Joyce, C. Wong, E. Priestley, 1997, Journal of the American Chemical Society.

Hydroxyamines as a New Motif for the Molecular Recognition of Phosphodiesters: Implications for Aminogloycoside–RNA Interactions

Chi‐Huey Wong, E. Priestley, M. Hendrix, 1997 .

1-Aminocyclopropaneboronic acid: synthesis and incorporation into an inhibitor of hepatitis C virus NS3 protease.

C. Decicco, E. Priestley, 2000, Organic letters.

The synthesis and evaluation of a novel class of (E)-3-(1-cyclohexyl-1H-pyrazol-3-yl)-2-methylacrylic acid hepatitis C virus polymerase NS5B inhibitors.

Carl T. Bergstrom, B. Beno, Scott W. Martin, 2011, Bioorganic & medicinal chemistry letters.

BMS-593214, an active site-directed factor VIIa inhibitor: Enzyme kinetics, antithrombotic and antihaemostatic studies

R. Knabb, A. Rendina, B. Xin, 2017 .

Direct observation of aminoglycoside-RNA interactions by surface plasmon resonance.

G. F. Joyce, C. Wong, E. Priestley, 1997, Journal of the American Chemical Society.

Discovery of BMS-986308: A Renal Outer Medullary Potassium Channel Inhibitor for the Treatment of Heart Failure.

A. Mathur, E. Priestley, J. M. Richter, 2024, Journal of medicinal chemistry.